Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction.
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of a 24 hour infusion with
levosimendan in patients with acute myocardial infarction and heart failure after acute
percutaneous coronary intervention (PCI) treatment.